ERC, MSCA & EIC: Mastering Horizon Europe's Flagship Instruments

The European Research Council (ERC), Marie Skłodowska-Curie Actions (MSCA), and European Innovation Council (EIC) represent Horizon Europe's most prestigious funding instruments, collectively managing over €10.1 billion in annual support for researchers, innovators, and entrepreneurs. These three flagship programmes address distinct phases of the innovation pipeline — from frontier research through researcher development to breakthrough commercialisation — making them cornerstone elements for any comprehensive EU funding strategy.

You'll find these programmes funding approximately 15,000+ individual researchers and over 2,000 companies annually according to the European Innovation Council, representing the largest concentration of excellence-based individual funding in the global research ecosystem. Understanding their distinct yet complementary roles is crucial for research organisations managing multi-instrument portfolios and supporting diverse researcher career paths.

What distinguishes ERC, MSCA, and EIC funding approaches?

The European Research Council (ERC) is a funding organisation that stimulates scientific excellence by supporting the very best creative researchers of any nationality, provided research is conducted in EU Member States or Associated Countries. ERC grants focus exclusively on frontier research with excellence as the sole evaluation criterion, offering substantial funding packages up to €2.5 million for Advanced Grants according to Horizon Europe programme guidance.

Marie Skłodowska-Curie Actions (MSCA) enhance researcher mobility and career development through international, interdisciplinary, and intersectoral training opportunities. MSCA Postdoctoral Fellowships support individual researchers undertaking mobility either to Europe or within Europe, with fellowship durations typically ranging 12-24 months and budgets reaching €399.05 million for 2026.

The European Innovation Council (EIC) supports game-changing innovations from concept to market, targeting startups and SMEs with breakthrough technologies. With over €2.024 billion allocated for 2026 according to the EIC Work Programme 2026, the EIC combines grants up to €2.5 million with equity investments up to €10 million, creating a unique blended financing approach.

The fundamental distinction lies in their target populations and objectives: ERC prioritises research excellence regardless of commercial potential, MSCA emphasises researcher development and mobility, while EIC focuses on innovation with clear commercialisation pathways and market disruption potential.

How do ERC grant levels match different career stages?

ERC grants are structured around three distinct career phases, each with specific eligibility windows and funding levels designed to support researchers at critical transition points. Many coordinators find that understanding these career-stage distinctions is essential for developing institutional researcher support strategies.

ERC Starting Grants target researchers 2-7 years post-PhD, providing up to €1.5 million plus potential €1 million additional funding for those relocating to Europe. This instrument specifically supports emerging research leaders establishing their first independent research group, with applicants demonstrating promising track records and innovative project proposals.

ERC Consolidator Grants serve researchers 7-12 years post-PhD, offering up to €2 million plus €1 million additional funding for international moves. These grants support researchers consolidating their independent research position, typically those who have demonstrated initial success but require substantial resources to achieve breakthrough discoveries.

ERC Advanced Grants support established researchers with at least 10 years of excellent track record, providing up to €2.5 million plus €1 million relocation funding. According to the Horizon Europe Programme Guide, these grants enable distinguished scientists to pursue ambitious, high-risk projects that could fundamentally advance their fields.

Time commitment requirements decrease with seniority: Starting Grant recipients must dedicate at least 50% of their working time to the project, Consolidator recipients 40%, and Advanced Grant holders 30%, reflecting increasing administrative and leadership responsibilities at senior levels. In practice, many institutions structure sabbaticals and teaching relief around these commitment levels.

Which mobility opportunities does MSCA provide for your researchers?

Marie Skłodowska-Curie Actions encompass multiple fellowship and training schemes designed to enhance researcher mobility, skills development, and career progression through international collaboration. You'll find that MSCA operates on the principle that mobility — geographical, sectoral, and interdisciplinary — is fundamental to researcher excellence and innovation capacity.

MSCA Postdoctoral Fellowships offer two mobility tracks: European Postdoctoral Fellowships for researchers of any nationality moving to or within Europe (12-24 months), and Global Postdoctoral Fellowships for European nationals or long-term residents undertaking outgoing mobility to third countries followed by mandatory 12-month return phases.

MSCA Doctoral Networks support collaborative research training through international partnerships, requiring consortia of at least three entities from different countries. These networks train doctoral candidates through joint supervision, secondments, and complementary skills development, with no more than 40% of funding allocated to beneficiaries in the same country according to the MSCA Work Programme 2026-2027.

The programme encourages intersectoral mobility between academic and non-academic sectors, supporting researchers working in industry, public organisations, and NGOs. This approach addresses the need for diverse career paths and knowledge transfer between sectors, particularly relevant for applied research areas and innovation-driven projects.

MSCA also supports researchers facing specific challenges, including those displaced by conflict and researchers seeking career restart opportunities, demonstrating the programme's commitment to inclusive excellence and researcher support during career transitions.

How does EIC blend grants and investments for breakthrough innovation?

The European Innovation Council pioneered a unique blended financing model that combines grants and equity investments to support high-risk, high-impact innovation projects throughout their development lifecycle. This approach addresses the traditional "valley of death" between research and commercialisation by providing both risk capital and patient investment.

EIC Accelerator grants provide up to €2.5 million in lump sum funding for innovation activities at Technology Readiness Levels (TRL) 6-8, supporting prototype development, demonstration, and early validation phases. These grants are designed to help companies reach market-ready maturity within 24-month implementation periods.

The investment component offers €1-10 million in direct equity or quasi-equity financing, including convertible loans, to support scale-up activities. According to the EIC Work Programme 2026, this patient capital principle recognises that breakthrough innovations often require longer development timelines than traditional venture capital can support.

You can access three funding modalities: grant-only for those with scale-up capacity, investment-only for rapid scaling without grant needs, or blended finance combining both instruments. The EIC Fund operates as a direct equity investor, taking minority stakes and providing access to Business Acceleration Services including coaching, mentoring, and ecosystem connections.

EIC Programme Managers actively manage innovation portfolios, bringing domain expertise and strategic oversight to funded projects. This hands-on approach distinguishes EIC from traditional funding agencies, creating a venture capital-style environment within the public funding framework. Many coordinators report that this active management significantly enhances project success rates.

What are the eligibility requirements for each flagship instrument?

Each flagship instrument maintains distinct eligibility criteria reflecting their specific objectives and target populations, though all share Horizon Europe's fundamental requirement for research and innovation activities in EU Member States or Associated Countries.

ERC eligibility focuses primarily on researcher excellence rather than institutional affiliation. Principal investigators of any nationality can apply provided the research is conducted in eligible countries, with no restrictions on research domain or methodology. The key requirement is demonstrated research excellence appropriate to the grant level, with specific time windows post-PhD for Starting and Consolidator Grants.

MSCA Postdoctoral Fellowship eligibility requires PhD completion and compliance with mobility rules: applicants cannot have resided or worked in the host country for more than 12 months in the 36 months preceding the deadline. European Fellowships welcome researchers of any nationality, while Global Fellowships are restricted to European nationals or long-term residents.

EIC Accelerator targets single startups, SMEs, and individuals intending to establish SMEs, with small mid-cap companies eligible for investment-only support. Applicants must demonstrate game-changing innovation potential, clear commercialisation pathways, and capacity to scale internationally. The three-step evaluation process includes short proposal submission, full proposal development, and face-to-face interviews with evaluation panels.

All programmes utilise the Funding & Tenders Portal for applications, with ERC and MSCA following traditional academic evaluation timelines (6-9 months), while EIC operates continuous assessment cycles with faster turnaround times (4-6 months) reflecting its commercial orientation and startup needs.

How can your organisation position itself strategically across all three instruments?

Research organisations managing comprehensive EU funding portfolios must understand the strategic complementarities between ERC, MSCA, and EIC instruments to maximise their institutional impact and researcher support capabilities. These programmes operate as interconnected elements of the European research and innovation ecosystem, requiring coordinated institutional approaches.

Leading research institutions typically develop multi-layered strategies encompassing all three instruments. They support excellent researchers through ERC applications while simultaneously building international collaboration networks through MSCA partnerships and commercialising research outputs via EIC pathways. This approach requires dedicated support infrastructure including specialised grant offices, technology transfer capabilities, and industry liaison functions.

The programmes exhibit natural progression pathways: ERC-funded researchers often transition to MSCA mobility opportunities for international collaboration, while breakthrough research outcomes can evolve into EIC-supported spin-offs and startups. Institutions that recognise and facilitate these transitions demonstrate superior performance in innovation metrics and researcher retention.

Successful organisations invest in cross-programme coordination, ensuring ERC grantees receive commercialisation support, MSCA fellows access continuing funding opportunities, and EIC participants benefit from academic collaboration networks. This integrated approach maximises the European Added Value that Horizon Europe seeks to achieve through its flagship instruments.

The combined impact of these three instruments creates a comprehensive European talent and innovation ecosystem, positioning Europe as a global leader in research excellence, researcher mobility, and breakthrough innovation. Understanding their interconnections enables research organisations to build sustainable competitive advantages in the global research landscape.

Frequently Asked Questions

Can researchers from outside Europe apply for ERC grants?

Yes, ERC grants are open to researchers of any nationality worldwide, provided the research is conducted in an EU Member State or Associated Country. Non-European researchers moving to Europe can receive additional funding up to €1 million to support their relocation and research setup.

What are the typical success rates for ERC, MSCA, and EIC applications?

Success rates vary significantly across programmes: ERC grants typically achieve 10-15% success rates reflecting intense competition for research excellence, MSCA Postdoctoral Fellowships reach 15-20% due to mobility requirements, while EIC Accelerator maintains around 3-5% reflecting its focus on breakthrough commercial innovation with high market potential.

Can the same researcher apply to multiple flagship programmes simultaneously?

Yes, researchers can apply to multiple programmes simultaneously, though each has distinct eligibility criteria and objectives. Many successful institutions encourage strategic portfolio approaches combining ERC research excellence with MSCA mobility opportunities and potential EIC commercialisation pathways for maximum impact.

How do resubmission policies differ between these three programmes?

ERC allows unlimited resubmissions with mandatory waiting periods between attempts. MSCA introduced restrictions from 2022: proposals scoring below 70% (Postdoctoral) or 80% (Doctoral Networks) cannot resubmit to the following year's call. EIC has specific resubmission guidelines within its three-step evaluation process depending on the evaluation stage reached.

What additional support services are available beyond direct funding?

All programmes offer extensive support ecosystems: ERC provides research portability between institutions and career development support, MSCA includes comprehensive training programmes and international networking opportunities, while EIC offers Business Acceleration Services including dedicated coaching, mentoring, and access to global innovation networks and investors.